Cannabidiol (CBD) is an abundant component of the cannabis (marijuana) plant and has many proven therapeutic uses including creating an anti-inflammatory effect on many disease conditions.
Diabetes can lead to diabetic cardiomyopathy, which involves heart dysfunction, inflammation, oxidative stress, cell death and more. In this study, CBD was evaluated for its effects on type I diabetic cardiomyopathy in a mouse model.
Remarkably, treatment with CBD reduced cardiac dysfunction, fibrosis, oxidative stress, inflammation, cell death and other positive chemical markers. The authors state CBD may have great therapeutic potential for treatment of diabetic complications and perhaps in other cardiac disorders as well.
